Document
IPR2017-01053, No. 2030 Exhibit - Curriculum Vitae of Henry Grabowski, PhD (P.T.A.B. Dec. 22, 2017)
Cite Document
IPR2017-01053, No. 2030 Exhibit - Curriculum Vitae of Henry Grabowski, PhD (P.T.A.B. Dec. 22, 2017)
+ More Snippets
Document
IPR2017-01053, No. 1092 Exhibit - Ex 1092 Buys (P.T.A.B. May. 1, 2018)
Cite Document
IPR2017-01053, No. 1092 Exhibit - Ex 1092 Buys (P.T.A.B. May. 1, 2018)
+ More Snippets
Document
IPR2017-01053, No. 1099 Exhibit - Ex 1099 (P.T.A.B. May. 1, 2018)
Cite Document
IPR2017-01053, No. 1099 Exhibit - Ex 1099 (P.T.A.B. May. 1, 2018)
+ More Snippets
Document
IPR2017-01053, No. 2010 Exhibit - Alcon Laboratory Notebook No 10545, p 51 (P.T.A.B. Dec. 22, 2017)
Cite Document
IPR2017-01053, No. 2010 Exhibit - Alcon Laboratory Notebook No 10545, p 51 (P.T.A.B. Dec. 22, 2017)
+ More Snippets
Document
IPR2017-01053, No. 2056 Exhibit - TRAVATAN Z¿¿ and Other Prostaglandin Analog Drugs,Formulary Placement for Commercial Plans 2017¿¿¿2018 (P.T.A.B. Dec. 22, 2017)
Cite Document
IPR2017-01053, No. 2056 Exhibit - TRAVATAN Z¿¿ and Other Prostaglandin Analog Drugs,Formulary Placement for Commercial Plans 2017¿¿¿2018 (P.T.A.B. Dec. 22, 2017)
+ More Snippets
Document
IPR2017-01053, No. 2054 Exhibit - TRAVATAN Z¿¿, TRAVATAN¿¿, and LUMIGAN¿¿, Promotional Spending Excluding Retail Value of Samples (P.T.A.B. Dec. 22, 2017)
Cite Document
IPR2017-01053, No. 2054 Exhibit - TRAVATAN Z¿¿, TRAVATAN¿¿, and LUMIGAN¿¿, Promotional Spending Excluding Retail Value of Samples (P.T.A.B. Dec. 22, 2017)
+ More Snippets
Document
IPR2017-01053, No. 1094 Exhibit - Ex 1094 Staines (P.T.A.B. May. 1, 2018)
Cite Document
IPR2017-01053, No. 1094 Exhibit - Ex 1094 Staines (P.T.A.B. May. 1, 2018)
+ More Snippets
Document
IPR2017-01053, No. 2016 Exhibit - Alcon Laboratory Notebook No 11781, pp 81¿¿¿83 (P.T.A.B. Dec. 22, 2017)
Cite Document
IPR2017-01053, No. 2016 Exhibit - Alcon Laboratory Notebook No 11781, pp 81¿¿¿83 (P.T.A.B. Dec. 22, 2017)
+ More Snippets
Document
IPR2017-01053, No. 2041 Exhibit - TRAVATAN Z¿¿ Wholesale Dollar Sales (P.T.A.B. Dec. 22, 2017)
Cite Document
IPR2017-01053, No. 2041 Exhibit - TRAVATAN Z¿¿ Wholesale Dollar Sales (P.T.A.B. Dec. 22, 2017)
+ More Snippets
Document
IPR2017-01053, No. 1080 Exhibit - Ex 1080 (P.T.A.B. May. 1, 2018)
Cite Document
IPR2017-01053, No. 1080 Exhibit - Ex 1080 (P.T.A.B. May. 1, 2018)
+ More Snippets
Document
IPR2017-01053, No. 1075 Exhibit - Ex 1075 (P.T.A.B. May. 1, 2018)
Cite Document
IPR2017-01053, No. 1075 Exhibit - Ex 1075 (P.T.A.B. May. 1, 2018)
+ More Snippets
Document
IPR2017-01053, No. 2027 Exhibit - Declaration of Richard K Parrish, II, MD (P.T.A.B. Dec. 22, 2017)
Cite Document
IPR2017-01053, No. 2027 Exhibit - Declaration of Richard K Parrish, II, MD (P.T.A.B. Dec. 22, 2017)
+ More Snippets
Document
IPR2017-01053, No. 2049 Exhibit - TRAVATAN Z¿¿, TRAVATAN¿¿, and LUMIGAN¿¿, Cumulative Wholesale Dollar Sales (P.T.A.B. Dec. 22, 2017)
Cite Document
IPR2017-01053, No. 2049 Exhibit - TRAVATAN Z¿¿, TRAVATAN¿¿, and LUMIGAN¿¿, Cumulative Wholesale Dollar Sales (P.T.A.B. Dec. 22, 2017)
+ More Snippets
Document
IPR2017-01053, No. 2055 Exhibit - TRAVATAN Z¿¿ and Other Prostaglandin Analog Drugs,Formulary Placement for Commercial Plans 2017¿¿¿2018 (P.T.A.B. Dec. 22, 2017)
Cite Document
IPR2017-01053, No. 2055 Exhibit - TRAVATAN Z¿¿ and Other Prostaglandin Analog Drugs,Formulary Placement for Commercial Plans 2017¿¿¿2018 (P.T.A.B. Dec. 22, 2017)
+ More Snippets
Document
IPR2017-01053, No. 2050 Exhibit - Number of Prescriptions for TRAVATAN¿¿ (P.T.A.B. Dec. 22, 2017)
Cite Document
IPR2017-01053, No. 2050 Exhibit - Number of Prescriptions for TRAVATAN¿¿ (P.T.A.B. Dec. 22, 2017)
+ More Snippets